Terms: = Pancreatic cancer AND ERCC2, TTD, 2068, ENSG00000104884, COFS2, P18074, MGC102762, XPD, MGC126219, MGC126218, EM9
36 results:
1. Investigating the impact of tumor location and size on the risk of recurrence for papillary thyroid carcinoma in the isthmus.
Zhu F; Li F; Xie X; Wu Y; Wang W
Cancer Med; 2023 Jun; 12(12):13290-13299. PubMed ID: 37132252
[TBL] [Abstract] [Full Text] [Related]
2. Presence of PD-1 similarity genes in monocytes may promote the development of type 1 diabetes mellitus and poor prognosis of pancreatic cancer.
Huang Y; Zhang W; Xu C; Li Q; Zhang W; Xu W; Zhang M
BMJ Open Diabetes Res Care; 2023 May; 11(3):. PubMed ID: 37130628
[TBL] [Abstract] [Full Text] [Related]
3. FOLFIRINOX or gemcitabine/nab-paclitaxel in advanced pancreatic adenocarcinoma: A novel validated prognostic score to facilitate treatment decision-making in real-world.
Marschner N; Hegewisch-Becker S; Reiser M; von der Heyde E; Bertram M; Hollerbach SH; Kreher S; Wolf T; Binninger A; Chiabudini M; Kaiser-Osterhues A; Jänicke M;
Int J Cancer; 2023 Feb; 152(3):458-469. PubMed ID: 36053905
[TBL] [Abstract] [Full Text] [Related]
4. Plant Alkaloid Tetrandrine Is a Nuclear Receptor 4A1 Antagonist and Inhibits Panc-1 Cell Growth In Vitro and In Vivo.
Lee HS; Kim DH; Lee IS; Park JH; Martin G; Safe S; Kim KJ; Kim JH; Jang BI; Lee SO
Int J Mol Sci; 2022 May; 23(9):. PubMed ID: 35563670
[TBL] [Abstract] [Full Text] [Related]
5. C-reactive protein trajectories and the risk of all cancer types: A prospective cohort study.
Liu T; Zhang Q; Song C; Siyin ST; Chen S; Zhang Q; Song M; Cao L; Shi H
Int J Cancer; 2022 Jul; 151(2):297-307. PubMed ID: 35368093
[TBL] [Abstract] [Full Text] [Related]
6. Association Studies of ercc2 rs13181 Polymorphism with pancreatic cancer Susceptibility.
Shao T; Kou J
Crit Rev Eukaryot Gene Expr; 2021; 31(2):17-23. PubMed ID: 34347976
[TBL] [Abstract] [Full Text] [Related]
7. Progression vs Cyst Stability of Branch-Duct Intraductal Papillary Mucinous Neoplasms After Observation and Surgery.
Marchegiani G; Pollini T; Andrianello S; Tomasoni G; Biancotto M; Javed AA; Kinny-Köster B; Amini N; Han Y; Kim H; Kwon W; Kim M; Perri G; He J; Bassi C; Goh BK; Katz MH; Jang JY; Wolfgang C; Salvia R
JAMA Surg; 2021 Jul; 156(7):654-661. PubMed ID: 34009303
[TBL] [Abstract] [Full Text] [Related]
8. Ramucirumab in the second-line for patients with hepatocellular carcinoma and elevated alpha-fetoprotein: patient-reported outcomes across two randomised clinical trials.
Zhu AX; Nipp RD; Finn RS; Galle PR; Llovet JM; Blanc JF; Okusaka T; Chau I; Cella D; Girvan A; Gable J; Bowman L; Wang C; Hsu Y; Abada PB; Kudo M
ESMO Open; 2020 Aug; 5(4):. PubMed ID: 32817068
[TBL] [Abstract] [Full Text] [Related]
9. Association of ERCC1 and ercc2 Gene Polymorphisms with pancreatic cancer Risk: A Meta-Analysis.
Xie F; Sun Q; Zhang E; Mu Y
Crit Rev Eukaryot Gene Expr; 2020; 30(3):231-237. PubMed ID: 32749109
[TBL] [Abstract] [Full Text] [Related]
10. Genetic polymorphisms and pancreatic cancer risk: A PRISMA-compliant systematic review and meta-analysis.
Dai P; Li J; Li W; Qin X; Wu X; Di W; Zhang Y
Medicine (Baltimore); 2019 Aug; 98(32):e16541. PubMed ID: 31393355
[TBL] [Abstract] [Full Text] [Related]
11. Utilising network pharmacology to explore the underlying mechanism of Wumei Pill in treating pancreatic neoplasms.
Wan Y; Xu L; Liu Z; Yang M; Jiang X; Zhang Q; Huang J
BMC Complement Altern Med; 2019 Jul; 19(1):158. PubMed ID: 31272505
[TBL] [Abstract] [Full Text] [Related]
12. [Mining and discovery for active components of "Coptidis Rhizome-Magnoliae Officinalis Cortex" based on network pharmacology].
Wu HN; Yu GH; Zhao FZ; Jia XB; Feng L; Shi XH
Zhongguo Zhong Yao Za Zhi; 2019 Feb; 44(4):803-810. PubMed ID: 30989895
[TBL] [Abstract] [Full Text] [Related]
13. pancreaticoduodenectomy in the surgical management of primary retroperitoneal sarcoma.
Tseng WW; Tsao-Wei DD; Callegaro D; Grignani G; D'Ambrosio L; Bonvalot S; Ethun CG; Cardona K; Mullen JT; Canter RJ; Mullinax JE; Gonzalez RJ; van Coevorden F; Albertsmeier M; Dhanireddy KK; Renne SL; Gronchi A;
Eur J Surg Oncol; 2018 Jun; 44(6):810-815. PubMed ID: 29452860
[TBL] [Abstract] [Full Text] [Related]
14. Comparison of treatment patterns, resource utilization, and cost of care in patients with metastatic pancreatic cancer treated with first-line nab-paclitaxel plus gemcitabine or FOLFIRINOX.
Kim GP; Parisi MF; Patel MB; Pelletier CL; Belk KW
Expert Rev Clin Pharmacol; 2017 May; 10(5):559-565. PubMed ID: 28286977
[TBL] [Abstract] [Full Text] [Related]
15. Association between ercc2 Lys751Gln polymorphism and the risk of pancreatic cancer, especially among Asians: evidence from a meta-analysis.
Wu Y; Lu ZP; Zhang JJ; Liu DF; Shi GD; Zhang C; Qin ZQ; Zhang JZ; He Y; Wu PF; Miao Y; Jiang KR
Oncotarget; 2017 Jul; 8(30):50124-50132. PubMed ID: 28223548
[TBL] [Abstract] [Full Text] [Related]
16. Gemcitabine-erlotinib versus gemcitabine-erlotinib-capecitabine in the first-line treatment of patients with metastatic pancreatic cancer: Efficacy and safety results of a phase IIb randomised study from the Spanish ttd Collaborative Group.
Irigoyen A; Gallego J; Guillén Ponce C; Vera R; Iranzo V; Ales I; Arévalo S; Pisa A; Martín M; Salud A; Falcó E; Sáenz A; Manzano Mozo JL; Pulido G; Martínez Galán J; Pazo-Cid R; Rivera F; García García T; Serra O; Fernández Parra EM; Hurtado A; Gómez Reina MJ; López Gomez LJ; Martínez Ortega E; Benavides M; Aranda E;
Eur J Cancer; 2017 Apr; 75():73-82. PubMed ID: 28222309
[TBL] [Abstract] [Full Text] [Related]
17. Association between ERCC1 and ercc2 gene polymorphisms and susceptibility to pancreatic cancer.
He MG; Zheng K; Tan D; Wang ZX
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27051038
[TBL] [Abstract] [Full Text] [Related]
18. Role of single nucleotide polymorphisms of DNA repair genes in susceptibility to pancreatic cancer in Chinese population.
Ying MF; Zhao R
Genet Mol Res; 2016 Mar; 15(1):. PubMed ID: 27050953
[TBL] [Abstract] [Full Text] [Related]
19. Association of single nucleotide polymorphisms of DNA repair genes in NER pathway and susceptibility to pancreatic cancer.
Zhao F; Shang Y; Zeng C; Gao D; Li K
Int J Clin Exp Pathol; 2015; 8(9):11579-86. PubMed ID: 26617894
[TBL] [Abstract] [Full Text] [Related]
20. ttd consensus document on the diagnosis and management of exocrine pancreatic cancer.
Benavides M; Abad A; Ales I; Carrato A; Díaz Rubio E; Gallego J; García-Foncillas J; Grávalos C; Laquente B; Pericay C; Rivera F; Tabernero J; Aranda E
Clin Transl Oncol; 2014 Oct; 16(10):865-78. PubMed ID: 24728654
[TBL] [Abstract] [Full Text] [Related]
[Next]
